MedPath

Vitamin D Time-Course Pilot Study

Completed
Conditions
Vitamin D insufficiency
Metabolic and Endocrine - Other metabolic and endocrine disorders
Registration Number
ACTRN12606000434594
Lead Sponsor
Professor I.R. Reid
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Able to provide informed consent and have a high risk of vitamin D insufficiency.

Exclusion Criteria

Renal insufficiency (creatinine clearance < 20 ml/min).Major bone disorder, condition or drugs likely to affect calcium, parathyroid hormone or vitamin D metabolism.On high dose vitamin D or long-term steroids.Major systemic illness with a prognosis of 6 months or less.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to nadir of change in parathyroid hormone[Blood measurements taken at baseline and months 1, 3, 7, and 9.]
Secondary Outcome Measures
NameTimeMethod
Integrated response of parathyroid hormone (area under the curve), from blood measurements[Taken at baseline and months 1, 3, 7, and 9.];Serum 25(OH)D (from blood measurements taken at baseline and months 1, 3, 7, and 9)[ Taken at baseline and months 1, 3, 7, and 9.]
© Copyright 2025. All Rights Reserved by MedPath